31 related articles for article (PubMed ID: 37385383)
1. Pretreatment Circulating HPV16 DNA Viral Load Predicts Risk of Distant Metastasis in Patients with HPV16-Positive Oropharyngeal Cancer.
Mazurek AM; Jabłońska I; Kentnowski M; Kacorzyk U; Śnietura M; Rutkowski TW
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539498
[TBL] [Abstract][Full Text] [Related]
2. Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: Medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial.
Jones DA; Mistry P; Dalby M; Fulton-Lieuw T; Kong AH; Dunn J; Mehanna HM; Gray AM
Eur J Cancer; 2020 Jan; 124():178-185. PubMed ID: 31794928
[TBL] [Abstract][Full Text] [Related]
3. Overall survival, disease-free survival and quality of life in patients affected by HPV mediated p16+ oropharyngeal squamous cell carcinoma treated with upfront trans-oral robotic surgery vs radiotherapy or chemoradiotherapy.
Fiacchini G; Picariello M; Dallan I; Tricò D; Casani AP; Amato F; Paiar F; Ursino S; Berrettini S; Bruschini L
Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):1913-1921. PubMed ID: 38180604
[TBL] [Abstract][Full Text] [Related]
4. Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+ Oropharyngeal Squamous Cell Carcinoma.
Cao Y; Haring CT; Brummel C; Bhambhani C; Aryal M; Lee C; Heft Neal M; Bhangale A; Gu W; Casper K; Malloy K; Sun Y; Shuman A; Prince ME; Spector ME; Chinn S; Shah J; Schonewolf C; McHugh JB; Mills RE; Tewari M; Worden FP; Swiecicki PL; Mierzwa M; Brenner JC
Clin Cancer Res; 2022 Jan; 28(2):350-359. PubMed ID: 34702772
[TBL] [Abstract][Full Text] [Related]
5. Double trouble: Synchronous and metachronous primaries confound ctHPVDNA monitoring.
Naegele S; Efthymiou V; Hirayama S; Zhao BY; Das D; Chan AW; Richmon JD; Iafrate AJ; Faden DL
Head Neck; 2023 Jun; 45(6):E25-E30. PubMed ID: 37080924
[TBL] [Abstract][Full Text] [Related]
6. Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study.
Mehanna H; Rapozo D; von Zeidler SV; Harrington KJ; Winter SC; Hartley A; Nankivell P; Schache AG; Sloan P; Odell EW; Thavaraj S; Hunter KD; Shah KA; Thomas GJ; Long A; Amel-Kashipaz R; Brown RM; Conn B; Hall GL; Matthews P; Weir J; Yeo Y; Pring M; West CML; McCaul J; Golusinski P; Sitch A; Spruce R; Batis N; Bryant JL; Brooks JM; Jones TM; Buffa F; Haider S; Robinson M
Clin Cancer Res; 2024 Jan; 30(2):356-367. PubMed ID: 37870417
[TBL] [Abstract][Full Text] [Related]
7. De-escalating radiotherapy in HPV-positive oropharyngeal squamous cell carcinoma: how much is too little?
Dodhia VH; Penny F; Shanmugasundaram R; Patel N
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38262720
[TBL] [Abstract][Full Text] [Related]
8. Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma.
Haring CT; Bhambhani C; Brummel C; Jewell B; Bellile E; Heft Neal ME; Sandford E; Spengler RM; Bhangale A; Spector ME; McHugh J; Prince ME; Mierzwa M; Worden FP; Tewari M; Swiecicki PL; Brenner JC
Oncotarget; 2021 Jun; 12(13):1214-1229. PubMed ID: 34194620
[TBL] [Abstract][Full Text] [Related]
9. Cell-free human papillomavirus (HPV) DNA is a sensitive biomarker for prognosis and for early detection of relapse in locally advanced cervical cancer.
Sivars L; Jylhä C; Crona Guterstam Y; Zupancic M; Lindqvist B; Nordenskjöld M; Tham E; Hellman K
Clin Cancer Res; 2024 Apr; ():. PubMed ID: 38669077
[TBL] [Abstract][Full Text] [Related]
10. Tumor-stroma contact ratio - a novel predictive factor for tumor response to chemoradiotherapy in locally advanced oropharyngeal cancer.
Kaufmann J; Haist M; Kur IM; Zimmer S; Hagemann J; Matthias C; Grabbe S; Schmidberger H; Weigert A; Mayer A
Transl Oncol; 2024 Aug; 46():102019. PubMed ID: 38833784
[TBL] [Abstract][Full Text] [Related]
11. Tumor-Derived Exosomes and the Role of Liquid Biopsy in Human Papillomavirus Oropharyngeal Squamous Cell Carcinoma.
Allevato MM; Smith JD; Brenner MJ; Chinn SB
Cancer J; 2023 Jul-Aug 01; 29(4):230-237. PubMed ID: 37471614
[TBL] [Abstract][Full Text] [Related]
12. Performance of Liquid Biopsy for Diagnosis and Surveillance of Human Papillomavirus-Associated Oropharyngeal Cancer.
Ferrandino RM; Chen S; Kappauf C; Barlow J; Gold BS; Berger MH; Westra WH; Teng MS; Khan MN; Posner MR; Misiukiewicz KJ; Bakst RL; Sindhu KK; Genden EM; Chai RL; Roof SA
JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):971-977. PubMed ID: 37422913
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumour HPV16 DNA quantification - A prognostic tool for progression-free survival in patients with HPV-related oropharyngeal carcinoma receiving curative chemoradiotherapy.
Adrian G; Forslund O; Pedersen L; Sjövall J; Gebre-Medhin M
Radiother Oncol; 2023 Sep; 186():109773. PubMed ID: 37385383
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor HPV DNA complements PET-CT in guiding management after radiotherapy in HPV-related squamous cell carcinoma of the head and neck.
Tanaka H; Takemoto N; Horie M; Takai E; Fukusumi T; Suzuki M; Eguchi H; Komukai S; Tatsumi M; Isohashi F; Ogawa K; Yachida S; Inohara H
Int J Cancer; 2021 Feb; 148(4):995-1005. PubMed ID: 32895945
[TBL] [Abstract][Full Text] [Related]
15. Systematic evaluation and meta-analysis of the prognosis of down-staging human papillomavirus (HPV) positive oropharyngeal squamous cell carcinoma using cetuximab combined with radiotherapy instead of cisplatin combined with radiotherapy.
Hu Q; Li F; Yang K
PeerJ; 2024; 12():e17391. PubMed ID: 38784388
[TBL] [Abstract][Full Text] [Related]
16. Determinants of the level of circulating-tumor HPV16 DNA in patients with HPV-associated oropharyngeal cancer at the time of diagnosis.
Kentnowski M; Cortez AJ; Mazurek AM; Mrochem-Kwarciak J; Hebda A; Kacorzyk U; Drosik-Rutowicz K; Chmielik E; Paul P; Gajda K; Łasińska I; Bobek-Billewicz B; d'Amico A; Składowski K; Śnietura M; Faden DL; Rutkowski TW
Sci Rep; 2023 Dec; 13(1):21226. PubMed ID: 38040848
[TBL] [Abstract][Full Text] [Related]
17. Advances in the Management of HPV-Related Oropharyngeal Cancer.
De Felice F; Tombolini V; Valentini V; de Vincentiis M; Mezi S; Brugnoletti O; Polimeni A
J Oncol; 2019; 2019():9173729. PubMed ID: 31097964
[TBL] [Abstract][Full Text] [Related]
18. Circulating Tumor DNA in Human Papillomavirus-Mediated Oropharynx Cancer: Leveraging Early Data to Inform Future Directions.
Heft Neal ME; Walline HM; Haring CT
Cancer J; 2023 Jul-Aug 01; 29(4):215-219. PubMed ID: 37471611
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
